D.E. Shaw & Co’s PetMed Express PETS Stock Holding History

D.E. Shaw & Co’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-33,678	Closed	-$112K	–	4839
2025 Q2	$112K	Sell	33,678 -3,422	-9%	-$12.2K	﹤0.01%	4118
2025 Q1	$155K	Sell	37,100 -134,887	-78%	-$613K	﹤0.01%	3968
2024 Q4	$829K	Sell	171,987 -149,495	-47%	-$700K	﹤0.01%	3313
2024 Q3	$1.18M	Buy	321,482 +71,422	+29%	+$253K	﹤0.01%	3147
2024 Q2	$1.01M	Sell	250,060 -123,961	-33%	-$529K	﹤0.01%	3201
2024 Q1	$1.79M	Buy	374,021 +234,362	+168%	+$1.36M	﹤0.01%	2720
2023 Q4	$1.06M	Buy	139,659 +122,909	+734%	+$1.01M	﹤0.01%	3097
2023 Q3	$172K	Sell	16,750 -9,435	-36%	-$116K	﹤0.01%	3791
2023 Q2	$361K	Buy	+26,185	New	+$393K	﹤0.01%	3542
2022 Q4	–	Sell	-108,582	Closed	-$2.12M	–	5052
2022 Q3	$2.12M	Sell	108,582 -56,481	-34%	-$1.2M	﹤0.01%	2946
2022 Q2	$3.29M	Buy	165,063 +63,311	+62%	+$1.41M	﹤0.01%	2621
2022 Q1	$2.63M	Buy	101,752 +8,501	+9%	+$220K	﹤0.01%	3032
2021 Q4	$2.35M	Buy	93,251 +83,719	+878%	+$2.32M	﹤0.01%	3206
2021 Q3	$256K	Sell	9,532 -45,443	-83%	-$1.31M	﹤0.01%	4446
2021 Q2	$1.75M	Sell	54,975 -28,443	-34%	-$903K	﹤0.01%	3080
2021 Q1	$2.94M	Buy	83,418 +76,510	+1,108%	+$2.66M	﹤0.01%	2249
2020 Q4	$221K	Sell	6,908 -59,652	-90%	-$1.84M	﹤0.01%	3707
2020 Q3	$2.1M	Sell	66,560 -193,959	-74%	-$6.42M	﹤0.01%	2368
2020 Q2	$9.29M	Buy	260,519 +45,362	+21%	+$1.58M	0.01%	1226
2020 Q1	$6.19M	Sell	215,157 -45,699	-18%	-$1.2M	0.01%	1302
2019 Q4	$6.13M	Buy	260,856 +179,212	+220%	+$4.01M	0.01%	1572
2019 Q3	$1.47M	Buy	81,644 +33,518	+70%	+$553K	﹤0.01%	2582
2019 Q2	$754K	Buy	48,126 +20,033	+71%	+$394K	﹤0.01%	2845
2019 Q1	$640K	Sell	28,093 -73,134	-72%	-$1.65M	﹤0.01%	2871
2018 Q4	$2.35M	Buy	101,227 +53,692	+113%	+$1.43M	﹤0.01%	2022
2018 Q3	$1.57M	Sell	47,535 -31,838	-40%	-$1.19M	﹤0.01%	2369
2018 Q2	$3.5M	Buy	79,373 +49,252	+164%	+$1.91M	﹤0.01%	1788
2018 Q1	$1.26M	Sell	30,121 -183,426	-86%	-$8.47M	﹤0.01%	2342
2017 Q4	$9.72M	Buy	213,547 +202,206	+1,783%	+$7.97M	0.01%	1044
2017 Q3	$376K	Sell	11,341 -57,302	-83%	-$2.33M	﹤0.01%	3044
2017 Q2	$2.79M	Buy	68,643 +2,840	+4%	+$88K	﹤0.01%	1762
2017 Q1	$1.32M	Sell	65,803 -6,859	-9%	-$145K	﹤0.01%	2120
2016 Q4	$1.68M	Buy	72,662 +8,860	+14%	+$190K	﹤0.01%	2124
2016 Q3	$1.29M	Sell	63,802 -43,193	-40%	-$870K	﹤0.01%	2226
2016 Q2	$2.01M	Buy	106,995 +90,638	+554%	+$1.67M	﹤0.01%	1937
2016 Q1	$293K	Sell	16,357 -662	-4%	-$11.3K	﹤0.01%	3028
2015 Q4	$292K	Sell	17,019 -19,561	-53%	-$329K	﹤0.01%	3375
2015 Q3	$589K	Buy	36,580 +19,915	+120%	+$334K	﹤0.01%	2948
2015 Q2	$288K	Sell	16,665 -19,084	-53%	-$320K	﹤0.01%	3434
2015 Q1	$591K	Sell	35,749 -15,371	-30%	-$238K	﹤0.01%	2952
2014 Q4	$735K	Buy	51,120 +21,074	+70%	+$284K	﹤0.01%	3059
2014 Q3	$409K	Buy	+30,046	New	+$419K	﹤0.01%	3504
2014 Q2	–	Sell	-28,446	Closed	-$381K	–	4447
2014 Q1	$381K	Sell	28,446 -45,494	-62%	-$630K	﹤0.01%	3791
2013 Q4	$1.23M	Buy	73,940 +28,972	+64%	+$452K	﹤0.01%	2990
2013 Q3	$733K	Buy	+44,968	New	+$701K	﹤0.01%	3309

Other funds holding PETS

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

D.E. Shaw & Co's PETS Position: Q3 2025 in Review

D.E. Shaw & Co sold out of PetMed Express (PETS) in Q3 2025, closing a stake of 33,678 shares — an estimated $112K sold.

D.E. Shaw & Co first reported a position in PETS in Q3 2013 and held it in 45 quarters. The position peaked at $9.72M in Q4 2017. 59 funds tracked by Wall St. Rank hold PETS as of Q3 2025.

D.E. Shaw & Co reported no remaining PetMed Express position as of Q3 2025 after selling out during the quarter.
D.E. Shaw & Co sold 33,678 PetMed Express shares in Q3 2025, an estimated $112K.
D.E. Shaw & Co first reported a position in PetMed Express in Q3 2013 and held it in 45 quarters.
D.E. Shaw & Co's PetMed Express position peaked at $9.72M in Q4 2017.
59 funds tracked by Wall St. Rank held PetMed Express as of Q3 2025.

Based on D.E. Shaw & Co's 13F filing for Q3 2025, filed 14 Nov 2025.